Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQsadolescent-and-young-adult-medicine

Paeds SAQs · adolescent-and-young-adult-medicine

Gender diversity and gender-affirming paediatric care — formative SAQs

Two formative short-answer questions on the staged, reversible-first gender-affirming pathway, the minority-stress model, conversion-effort prohibition, and bone-health and fertility surveillance in trans and gender-diverse adolescents.

20 marks30 min
On this page & tools

Target exams

RACP General PaediatricsRACP DWERACP DCEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics

Target exams

RACP General PaediatricsRACP DWERACP DCEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
Prompt
Gender diversity and gender-affirming paediatric care

SAQ 1 — The peripubertal adolescent and pubertal suppression (10 marks)

A 12-year-old assigned male at birth has, since early childhood, been consistent, persistent and insistent about a female identity. With the onset of puberty she describes intensifying distress about penile growth and the prospect of voice deepening. Tanner stage 2 is confirmed. A multidisciplinary assessment supports a diagnosis of persistent gender dysphoria; she has capacity to assent and her parents consent. [2] [3]

Questions

  1. Outline the staged, reversible-first gender-affirming pathway, naming each stage and its reversibility. (5 marks) [2] [1]
  2. Justify pubertal suppression with a GnRH analogue at this point, and state the eligibility criteria that should be met before it is commenced. (3 marks) [2] [7]
  3. Describe the bone-health surveillance required while she is on suppression and explain why. (2 marks) [10]

Model answer

Staged, reversible-first pathway (5). The pathway moves from the most reversible to the least reversible step, with psychosocial support throughout. Stage 1 is exploration and psychosocial support — open, non-directive counselling, treatment of comorbidity, family and school work — and is fully reversible. Stage 2 is social transition (affirmed name, pronouns, appearance, environment), also fully reversible. Stage 3 is pubertal suppression with a GnRH analogue, fully reversible. Stage 4 is gender-affirming hormones (oestrogen or testosterone), typically from mid-adolescence in specialist programmes, partially reversible. Stage 5 is gender-affirming surgery, largely irreversible and usually an adult-service option, with chest masculinisation occasionally considered in older, long-persistent adolescents. [2] [1] [3]

Justification and eligibility for suppression (3). Suppression at Tanner 2 prevents the unwanted, increasingly permanent secondary sex characteristics of endogenous puberty that drive much of the distress, and buys decision-making time without closing any future door — it is fully reversible, and stopping it allows endogenous puberty to resume. Eligibility: persistent, well-documented gender dysphoria; an accurate early pubertal (Tanner 2) stage; multidisciplinary specialist assessment; any comorbid mental-health condition addressed; and the young person's assent together with parental (or legal) consent. [2] [7]

Bone-health surveillance (2). Adolescence is when sex steroids drive bone-mineral accrual; a GnRH analogue pauses that accrual, so density drifts down relative to peers during suppression and recovers only partially and later. Surveillance therefore includes baseline and periodic DXA, optimisation of calcium and vitamin D, and encouragement of weight-bearing activity. [10]

SAQ 2 — Family rejection, conversion request and minority stress (10 marks)

The father of a 15-year-old trans boy on pubertal suppression refuses to use his chosen name and pronouns, describes him as 'confused', and asks the clinician to arrange therapy 'to help him accept the body he was born with'. The young person discloses recent low mood and passive thoughts that life is not worth living, without active plan or intent. [1] [8]

Questions

  1. Explain the mechanism by which family rejection and minority stress contribute to the excess mental-health burden in trans and gender-diverse youth, and name the strongest protective and risk factors. (4 marks) [1] [8]
  2. State your response to the father's request for therapy to change identity, with reasoning. (3 marks) [8]
  3. Outline the immediate management of the low mood and passive suicidal thoughts, including the threshold for overriding confidentiality. (3 marks) [1] [7]

Model answer

Minority-stress mechanism and protective/risk factors (4). The excess mental-health burden is driven largely by minority stress — the chronic accumulation of external stressors (stigma, rejection, bullying, misgendering) and internal stressors (internalised transphobia, concealment, anticipation of rejection) — rather than by the identity itself. Family rejection is the single strongest risk factor for suicide, homelessness and poor mental health; family acceptance, an affirmed name and pronouns, a supportive school and peer environment, and access to gender-affirming care are the protective factors. The father's behaviour is therefore itself a contributor to the young person's distress. [1] [8]

Response to the conversion request (3). Any intervention intended to change a young person's gender identity is a conversion effort, which is associated with marked increases in psychological distress and suicide attempts and is ethically indefensible. The clinician should clearly decline, explain the harms of conversion and the affirmative, exploratory model, offer family psychoeducation, and connect the family to affirming support. The family's wishes do not override evidence-based, rights-based care. [8]

Management of low mood and passive thoughts (3). Perform a structured suicide-risk assessment (ideation, plan, intent, means, prior attempts, protective factors) and address safety. Passive thoughts without active plan or intent, with intact protective factors and superficial or no self-harm, may be managed with early close follow-up, a safety plan, psychological support, and continued affirming care — while respecting confidentiality. Escalation to active plan or intent, or loss of protective factors, triggers the serious-harm threshold: secure immediate safety, share the minimum necessary with the crisis team and family as part of the safety plan, and tell the young person what is shared and why. [1] [7]

References

  1. [1]Rafferty J, Yogman M, Committee on Psychosocial Aspects of Child and Family Health, et al Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents. Pediatrics, 2018.PMID 30224363
  2. [2]Hembree WC, Cohen-Kettenis PT, Gooren L, et al Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2017.PMID 28945902
  3. [3]Coleman E, Radix AE, Bouman WP, et al Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health, 2022.PMID 36238954
  4. [7]Turban JL, King D, Carswell JM, Keuroghlian AS Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation. Pediatrics, 2020.PMID 31974216
  5. [8]Turban JL, Beckwith N, Reisner SL, Keuroghlian AS Association Between Recalled Exposure to Gender Identity Conversion Efforts and Psychological Distress and Suicide Attempts Among Transgender Adults. JAMA Psychiatry, 2020.PMID 31509158
  6. [10]Vlot MC, Klink DT, den Heijer M, et al Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone, 2017.PMID 27845262
  7. [13]Steensma TD, McGuire JK, Kreukels BPC, Beekman AJ, Cohen-Kettenis PT Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. J Am Acad Child Adolesc Psychiatry, 2013.PMID 23702447